Long Road Investment Counsel’s Gilead Sciences GILD Stock Holding History

Long Road Investment Counsel’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.48M	Buy	24,950 +1,000	+4%	+$140K	1.36%	24
2025 Q4	$2.94M	Sell	23,950 -450	-2%	-$54.7K	1.11%	28
2025 Q3	$2.71M	Hold	24,400	–	–	0.96%	29
2025 Q2	$2.71M	Sell	24,400 -150	-0.6%	-$16K	1.01%	33
2025 Q1	$2.75M	Buy	24,550 +300	+1%	+$31K	1.07%	30
2024 Q4	$2.24M	Hold	24,250	–	–	0.91%	32
2024 Q3	$2.03M	Hold	24,250	–	–	0.81%	34
2024 Q2	$1.66M	Hold	24,250	–	–	0.72%	35
2024 Q1	$1.78M	Buy	24,250 +300	+1%	+$23.1K	0.74%	33
2023 Q4	$1.87M	Sell	23,950 -600	-2%	-$46.7K	0.78%	33
2023 Q3	$1.84M	Sell	24,550 -50	-0.2%	-$3.85K	0.89%	31
2023 Q2	$1.9M	Hold	24,600	–	–	0.88%	30
2023 Q1	$2.04M	Sell	24,600 -400	-2%	-$33.1K	0.98%	31
2022 Q4	$2.15M	Sell	25,000 -600	-2%	-$47.5K	1.07%	30
2022 Q3	$1.58M	Hold	25,600	–	–	0.87%	31
2022 Q2	$1.58M	Buy	25,600 +600	+2%	+$37.1K	0.81%	35
2022 Q1	$1.49M	Sell	25,000 -600	-2%	-$38.4K	0.67%	39
2021 Q4	$1.86M	Hold	25,600	–	–	0.74%	39
2021 Q3	$1.79M	Hold	25,600	–	–	0.79%	37
2021 Q2	$1.76M	Hold	25,600	–	–	0.77%	39
2021 Q1	$1.66M	Hold	25,600	–	–	0.75%	38
2020 Q4	$1.49M	Buy	25,600 +1,000	+4%	+$60.3K	0.72%	40
2020 Q3	$1.55M	Sell	24,600 -1,000	-4%	-$69.3K	0.88%	36
2020 Q2	$1.97M	Hold	25,600	–	–	1.16%	30
2020 Q1	$1.91M	Buy	25,600 +1,000	+4%	+$69.1K	1.37%	27
2019 Q4	$1.6M	Sell	24,600 -1,000	-4%	-$65.1K	0.94%	36
2019 Q3	$1.62M	Hold	25,600	–	–	0.94%	32
2019 Q2	$1.73M	Hold	25,600	–	–	1.02%	31
2019 Q1	$1.66M	Buy	25,600 +1,000	+4%	+$66.5K	1.02%	32
2018 Q4	$1.54M	Sell	24,600 -300	-1%	-$21K	1.18%	30
2018 Q3	$1.92M	Sell	24,900 -100	-0.4%	-$7.55K	1.28%	31
2018 Q2	$1.77M	Hold	25,000	–	–	1.26%	31
2018 Q1	$1.89M	Sell	25,000 -300	-1%	-$23.8K	1.32%	29
2017 Q4	$1.81M	Sell	25,300 -500	-2%	-$38K	1.25%	29
2017 Q3	$2.09M	Sell	25,800 -2,400	-9%	-$184K	1.49%	26
2017 Q2	$2M	Hold	28,200	–	–	1.47%	28
2017 Q1	$1.92M	Buy	28,200 +50	+0.2%	+$3.52K	1.41%	27
2016 Q4	$2.02M	Sell	28,150 -100	-0.4%	-$7.43K	1.55%	23
2016 Q3	$2.23M	Sell	28,250 -100	-0.4%	-$8.12K	1.73%	18
2016 Q2	$2.37M	Hold	28,350	–	–	1.85%	17
2016 Q1	$2.6M	Hold	28,350	–	–	2.05%	15
2015 Q4	$2.87M	Hold	28,350	–	–	2.36%	13
2015 Q3	$2.78M	Buy	28,350 +400	+1%	+$44.4K	2.37%	13
2015 Q2	$3.27M	Sell	27,950 -300	-1%	-$32.8K	2.67%	12
2015 Q1	$2.77M	Buy	28,250 +2,850	+11%	+$289K	2.35%	16
2014 Q4	$2.39M	Buy	+25,400	New	+$2.63M	2.15%	16

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Long Road Investment Counsel's GILD Position: Q1 2026 in Review

Long Road Investment Counsel increased its Gilead Sciences (GILD) stake by 4.2% in Q1 2026, buying an estimated $140K and bringing the position to 24,950 shares worth $3.48M. The position accounts for 1.36% of the portfolio, ranked #24.

Long Road Investment Counsel first reported a position in GILD in Q4 2014 and has held it in 46 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Long Road Investment Counsel held 24,950 shares of Gilead Sciences worth $3.48M as of Q1 2026.
Long Road Investment Counsel bought 1,000 Gilead Sciences shares in Q1 2026, an estimated $140K.
Gilead Sciences made up 1.36% of Long Road Investment Counsel's portfolio in Q1 2026, its #24 holding.
Long Road Investment Counsel first reported a position in Gilead Sciences in Q4 2014 and has held it in 46 quarters since.
2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Long Road Investment Counsel's 13F filing for Q1 2026, filed 8 May 2026.